Cite
HARVARD Citation
Margolin, R. et al. (n.d.). P1–357: Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC‐001 (vanutide cridificar) for Alzheimer's disease. Alzheimer's & dementia. pp. P289-P290. [Online].